Uterine Fibroid: Clinical Trials

3 trials for Uterine Fibroid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Uterine Fibroid: new trials by email Literature Review of Uterine Fibroid trials Research Report on Uterine Fibroid

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Relugolix, Estradiol/norethindrone acetate - Heavy Menstrual Bleeding, Uterine Fibroid
Phase 3CompletedMyovant Sciences GmbH4772017-10-192024-05-09
LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Relugolix, Estradiol/norethindrone acetate, Relugolix placebo - Heavy Menstrual Bleeding, Uterine Fibroid
Phase 3CompletedMyovant Sciences GmbH3822017-06-142022-04-20
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Relugolix, Estradiol/norethindrone acetate, Estradiol/norethindrone acetate placebo - Heavy Menstrual Bleeding, Uterine Fibroid
Phase 3CompletedMyovant Sciences GmbH3882017-04-262022-04-19

Narrower conditions

Leiomyoma (3)  ·  Menorrhagia (3)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Hemorrhage (3)  ·  Menstruation Disturbances (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Connective and Soft Tissue (3)  ·  Neoplasms, Muscle Tissue (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Uterine Diseases (3)  ·  Uterine Hemorrhage (3)

Interventions

estradiol, norethindrone drug combination (3)  ·  relugolix (3)  ·  Estradiol (2)

Sponsors

Myovant Sciences GmbH (3)

Countries

Brazil (3)  ·  Poland (3)  ·  South Africa (3)  ·  United States (3)  ·  Belgium (2)  ·  Chile (2)  ·  Czechia (2)  ·  Hungary (2)  ·  Italy (2)  ·  United Kingdom (1)

Results publications

PMID 36357960, PMID 37477173, PMID 37863160, PMID 33596357, PMID 35415708, PMID 35675604, PMID 37183454, PMID 39466126, PMID 40320117

NIH funding

2016 (2), 2017 (1)